CARD 9 Antibodies

Santa Cruz Biotechnology offers a broad range of CARD 9 monoclonal antibodies for research focused on understanding immune system regulation. CARD 9 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CARD 9, or Caspase Recruitment Domain-containing protein 9, is essential for the immune response, particularly in the activation of NF-κB signaling pathways. CARD 9 plays a pivotal role in the recognition of pathogens and the subsequent activation of innate immune responses. Research has shown that CARD 9 is involved in multiple signaling cascades that regulate inflammation and immune cell function. Scientists studying CARD 9 have uncovered its significance in various inflammatory conditions and autoimmune disorders. Understanding CARD 9's function continues to reveal new insights into immune system regulation and potential therapeutic targets. Investigating CARD 9 helps researchers better comprehend the complexities of immune response mechanisms and their impact on human health. Santa Cruz Biotechnology monoclonal antibodies support scientists worldwide in advancing immunology research and developing new therapeutic strategies.